If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
Philips and Profound Medical Corp., a Toronto-based medical device company, announced a joint development agreement to support Profound Medical's proprietary TULSA (Transurethral Ultrasound Ablation) technology on Philips' Ingenia and Achieva 3T magnetic resonance imaging (MRI) systems. The technology is designed to treat patients with prostate cancer
DAIC Editor Dave Fornell shares some of the most innovative new technologies shown on the expo floor and discusses in ...
Image-guided radiation therapy (IGRT) affords greater accuracy of dose distribution during cancer treatment, allowing the radiation oncologist to see how a tumor is responding over the course of treatment. This has traditionally been accomplished with computed tomography (CT) or X-ray scans, which requires extra radiation exposure for the patient, with relatively poor contrast in soft tissue due to uniform electron density. Since treatment is only as good as the images provided, efforts are under way to find a better modality — and magnetic resonance imaging (MRI) may hold the answer.
The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action on radiation protection.
Pinnacle³ Auto-Planning from Philips is designed to simplify and accelerate intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) planning.
Philips announced the introduction of Lumify, its first app-based ultrasound solution that will extend the reach of ultrasound applications across the health continuum using mobile technology. The technology was unveiled at the Social Media and Critical Care (SMACC) conference, June 23-26, in Chicago.
IBA (Ion Beam Applications S.A.) and Royal Philips announced the signing of an exclusive agreement to enhance access to proton therapy in India. The alliance combines IBA’s strengths in proton therapy and Philips’ expertise in clinical informatics and innovative imaging techniques for therapy planning and guidance.
Royal Philips announced the introduction of HeartModelA.I., a new Anatomically Intelligent Ultrasound (AIUS) tool that brings advanced quantification, automated 3-D views and robust reproducibility to cardiac ultrasound imaging. Philips' fastest 3-D AIUS ultrasound measurement method was unveiled on its Epiq 7 ultrasound system during the American Society of Echocardiography (ASE) annual meeting in Boston.
More than 50 companies and organizations will display their latest products and services at the American Society of Echocardiography’s (ASE) 26th Annual Scientific Sessions, June 12-16 at in Boston, Mass. ASE 2015 is the world’s premier meeting for cardiovascular ultrasound practitioners, and promises a wealth of cutting-edge education, research, and the latest vendor technology.
In May, Group of Companies European Medical Center (GEMC) became the first private clinic in Russia to open a positron emission tomography (PET-CT) department producing its own pharmaceuticals. GEMC also opened a radiation cancer therapy department featuring two linear accelerators.